Purpose: To evaluate multi-parametric MRI features in predicting pathological response after 20 preoperative chemo-radiation therapy (CRT) for locally advanced rectal cancer (LARC).
Introduction
For locally advanced rectal cancer (LARC), the standard of care treatment is preoperative concurrent 55 chemo-radiation treatment (CRT) followed by total mesorectal excision (TME) (1) (2) . After CRT approximately 15%-27% of patients show a pathological complete response (pCR) (3) (4) . In those who achieve a pCR, some investigators have questioned the use of TME surgery, since TME is associated with significant morbidity and functional complications, particularly for abdominoperineal resection. HabrGama et al. suggested a "wait-and-see" policy based on the results that the clinical complete responders 60 had excellent long-term results regardless of surgical resection (5) . Maas et al. confirmed the results in a small prospective study (6). Furthermore, Borschitz and colleagues recently reported that the local recurrence rate was 0% for pCR who had been treated with local excision (7) . Accordingly, although still in debate, it is important to provide physicians with accurate information using non-invasive approaches to identify complete responders for an alternative surgical treatment such as sphincter-saving local 65 excision.
Previous studies have highlighted several imaging modalities for their capability to distinguish good responders from others for LARC. Examples are fludeoxyglucose positron-emission-tomography (FDG-PET) (8), T2-weighted magnetic resonance imaging (T2w-MRI) (9), dynamic-contrast-enhanced MR 70 (DCE-MRI) (10) and diffusion-weighted imaging (DWI) (11) (12) . However, all previous works focused on single imaging modality, which may have inherent limitations in prognostic prediction. It has been shown that T2w-MRI has limitations in the depiction of primary tumors and mesorectal fascia, or residual viable tumor from diffuse fibrotic change (13) (14) . Also FDG-PET suffers from limitations in interpreting fibrotic scar tissue and inflammation (15) . Functional MRI such as DWI with the apparent diffusion 75 coefficient (ADC) assesses the impedance of water molecules diffusion that is mostly dependent on the tissue cellularity (16) (17) (18) . DCE-MRI, on the other hand, measures a volume transfer constant, which is dependent on the perfusion and the permeability of the tumor vasculature (19) tumor biology is likely not a property of single imaging tool but instead needs information from a combination of multiple modalities. Moreover, all previous studies considered a tumor as a uniform entity 80 by using a mean value to depict the whole volume. This may have the potential risk of overlooking tumor heterogeneity. In some cases, the tumor can be sequestered and disappear partly or completely. In other cases, the tumor may undergo necrosis or liquefaction and become avascular or cystic. For this reason voxel-wise analysis is an important tool to interrogate the most viable portions of the tumor.
In this present work, we investigate the wealth of multi-parametric MR image features in prediction of 85 pathological response for LARC. Our work integrates the anatomical MRI for tumor phonotype extraction, perfusion MRI for blood flow and permeability analysis, and diffusion MRI for tissue microcirculation and cellularity evaluation. All imaging parameters were analyzed using both volumeaveraged and voxelized analysis.
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Methods and Materials
Patients
Consecutive patients with MRI-staged T3 or T4 rectal cancer without distant metastasis treated at a single institute between January 2012 and November 2014 were enrolled. All patients received preoperative chemoradiation followed by total mesorectal excision (TME) surgery. The treatment protocol and 95 timeline followed the National Comprehensive Cancer Network (NCCN) guideline. The radiation treatment included 50 Gy delivered for 25 fractions using IMRT technique. Concurrently, patients received capecitabine 825 mg/m 2 orally, b.i.d. for 5 consecutive weeks and oxaliplatin 100 mg/m 2 once every 3 weeks. One extra cycle of additional chemotherapy was administrated after CRT and before surgical resection. According to the recent meta-analysis of over 6171 patients, oral capecitabine and 5-100 fluorouracil (5-FU) can be used interchangeable for patients with colorectal cancer (20) . In the present study, our patients received FOLFOX-6 (5-fluorouracil plus oxaliplatin for 34 patients) or CapeOx (Capecitabine plus oxaliplatin for 14 patients) for the additional chemotherapy. Then after a recovery
Research. interval of two weeks, TME was performed by either anterior resection or abdomino-perineal resection.
All patients received MR examinations one to two weeks before the chemoradiation and one week before 105 surgery. The pathological staging served as the reference standard and was determined according to the 
MRI protocols
All patients were scanned in a single institute with 3.0 Telsa MR (Signa HDxt, GE Medical Systems, 120
Milwaukee, WI) using a phased-array body coil, one or two week(s) before the start of chemoradiation with fixed image protocols. No special bowel preparation was performed. The MR machine underwent quality assurance check on a monthly-basis by hospital radiological physicist and further maintained on a bi-monthly basis by the GE engineer to ensure the consistency of image quality. Axial T2-weighted (T2w fast spin echo sequence, TR/TE: 2840/131 msec, image resolution 0.49x0.49x4 mm) and T1-weighted 125 (T1w spin echo sequence, TR/TE: 460/7.4 msec) maps were acquired. Array spatial sensitivity encoding technique (ASSET) was used with acceleration factor of 2. Then multi-phase T1w were obtained using a 
Statistical Analysis
Individual variables were analyzed for significant differences using t-test and the Wilcoxon-MannWhitney test for non-normally distributed parameters. Group results were reported as mean ± standard deviations. Group difference comparison with a 2-sided p-value <0.05 was considered significant. The 165 univariate analysis was carried out to evaluate the ability of single descriptor to discriminate pCR from non-pCR and GR from non-GR. These analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL). Since many parameters were generated, and they were possibly highly correlated, a three-layer perceptron artificial neural network (ANN) was utilized to analyze the dataset. Two steps were involved, with the first step, feature selection, to identify an optimal feature and the second step, called feature 170 classification, to train an optimal ANN architecture for response prediction. (1) For the first step, all parameters were included as the input nodes for ANN modeling, and the output node was one representing responder/non-responder decision. The node in the hidden layer was set based on the formula of m = (n + l) 1/2 + α, where m is the number of the hidden nodes, and n is the number of nodes in the input layer, l is the number of nodes in the output layer, and α is a constant from 1 to 10 (24). In this 175 study, α was arbitrarily selected as 5 in the first step. The forward search strategy was used to search limited to no more than 3 for the pathological response prediction (11 pCR) and 4 for the TRG good response prediction (17 non-GR). (2) After the optimal feature set was identified, an optimal ANN architecture was trained for the response prediction as the second step. For training of the model, the feed-forward-back-propagation (FFBP) learning process was implemented. In forward processing, input layer was used to input the data, then hidden layer processed the data. Assume = is the synaptic 185 input to the neuron, is a vector of weights of a particular neuron at the t th step of learning, logistic sigmoid function is used as the activation function ( ) between neurons as,
The training started with small random numbers for the initial weightings, and calculated the error function from the output neuron with mean-square-error (MSE) equation as:
where and represent the desired and obtained outputs of the neurons respectively. The error from 190 equation above was then back propagated by updating the weights, , using gradient descent method.
The equation of weights adjustment of each neuron is:
where is the learning rate. The number of hidden nodes (from 2 to 31, with step size 1), the learning rate (0.1-0.7) were varied for the ANN training. The learning rate η regulates the stride of gradient descent algorithm for minimization of the learning error with higher number for fast convergence but a possibility 195 to jump over the global minimum. We adjusted the learning rate by increase 5% if the current error was less than the previous one, indicating moving in the right direction. Otherwise the system went back with smaller steep by decreasing the learning rate 15%. The learning process continued until converged to a predefined value (<0.001) or until the maximum number of iterations 1000 was reached. 7.12 (The Mathworks Inc., Natick, MA.). The final predictive performance of the response was investigated using four-fold cross-validation. The cohort was randomly separated into four partitions, with three partitions used as the training data sets and the remaining one as the testing set. ANN was optimized using the training data set, and the outcome of the testing data was then predicted by the optimized ANN 205 model. The training and testing were run 4 times and the average performance was reported as the crossvalidated performance. The prediction results were further interpreted using the receiver operating characteristic (ROC) curve.
Results
210
Patient Characteristics
A total of 48 patients (59.9±8.9 years, from 01/2012 -11/2014) were included in the study. Among which, 11 (23%) were classified as pathological complete response (pCR) and 37 (77%) were non-pCR, 31 were good responders (GR, TRG 0-1, 65%) and 17 were non-good responders (non-GR, TRG 2-3, 35%). The detailed clinical characteristics are listed in Table 1 . There were no statistical differences 215 between pCR vs. non-pCR or GR vs. non-GR groups in types of age, sex, and TNM stage. Figure 1 gives two patients' example, both at 60 years old (y/o) with mid-rectum cancer at stage of cT3N+M0. But after treatment, one became pCR and the other did not achieve pCR. No significant differences were observed from qualitative visual inspection.
220
Group Differences
The pCR and non-pCR groups were homogeneous with respect to pre-treatment tumor volume. information compared to conventional volume-averaged analysis in assessing the treatment outcome. In addition, although no imaging or serum test could precisely correlate with treatment outcome, these modalities, when used in combination, gave improved prognostication. 280
Currently, pathological evaluation of the surgical specimen is the only reliable surrogate marker that correlates with long-term oncological outcome. However, such data are available only after completion of all pre-operative treatment and surgery, which cannot be used as guidance for adjusting the therapeutic approach. Accordingly, development of non-invasive biomarkers with the potential to provide early 285 prediction is essential. Such biomarkers would aid in identifying those patients who are less likely to benefit from the current therapies for alternative treatment or intensive follow-up regimens and those who are likely to achieve pCR for tailored surgery strategies. treatment mean-ADC did not reliably predict good responders (defined as ypT0-2), differences could be observed for the high fraction of ADC values from the histogram (30) . This has been confirmed by our study that the higher portion of the histogram percentile values (50-80%) was lower in the pCR groups. A possible explanation is that tumors with high ADC values are likely to be more necrotic or edematous than solid or viable tumors (31) . Because necrotic/edematous areas are resistant to radiation, it may be 300 hypothesized that those tumors, and thus high pretreatment ADC values, would have less favorable treatment response. We did not find that the heterogeneity distribution of the ADC map showed
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on November 6, 2017. © 2016 American Association for Cancer clincancerres.aacrjournals.org Downloaded from differences between different response groups. This might be due to the relatively coarse image resolution of the diffusion weighted images that washed out the effect.
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Regarding the DCE-MRI, the experience for response prediction in rectal cancer is even more limited and the prognostic value is still unclear. Tong et al. reported that pre-treatment DCE parameter (Ktrans from Toft's model) was significantly higher in the pCR group (32) but Intven et al. could not achieve the same promising result (12, 33) . In addition, they claimed no additional value was found including DCE-MRI next to T2w imaging and DWI in an MRI protocol used for response assessment in LARC. What we 310 found was that the volume-averaged feature (mean-MSD) did not add any value in the final prediction after ANN training, but the heterogeneous enhancement as analyzed by texture features showed promising prognostic power. When replacing the mean-MSD with voxel-based texture analysis into the final model, the AUC in predicting pCR could increase from 0.74 to 0.84. Tumor is not a uniform unity. those imaging characteristics. However, how to utilize the full wealth of imaging radiomics warrants more investigation. Our result suggests the potential limitation of using summary mean-value in some 330 instances to evaluate treatment response as done by previous studies and highlights the potential of voxelized heterogeneity analysis.
The present study has some limitations. Firstly, the sample size is still limited compared to the relatively large number of predictors. As such, ANN was utilized instead of the conventional logistic regression 335 analysis due to its capacity to model complex relationships between independent and predictor variables, allowing the inclusion of a large number of variables. The training and testing were performed on the same set of patient data. In order to minimize the bias, 4-fold cross validation was used (36, 37). We randomly separated our patient data into four cohorts with three of them used for training while the remaining one cohort used for testing purpose. All the tests were run 4 times with the average value 340 reported as the cross-validated performance. Larger study is required to determine the prognostic power of all these parameters and a cutoff point by ROC with narrow confidence intervals. Furthermore, to control for model overfitting, the number of predictors should remain within 1/10-1/3 of the number in the dependent group. In the current study, the potential feature set was limited to no more than 3 for pathological complete response prediction (11 pCR) and 4 for the TRG good response prediction (17 non-345 GR). Nevertheless, large data samples are needed to allow for a full panel selection of image features, and better investigation of the true benefit using non-linear statistical models as ANN over conventional linear-based statistical analysis on large dimensional data, similar to what we have previously reported on breast cancer management (38). Also, we have limited time points for the DCE-MRI sequence. This prevents quantitative analysis using the pharmacokinetic models such as the generalized Toft's model. relativity, and other equipment parameters, and may be more reliable in the current data sample. Thirdly, 355 no precautions were taken to avoid bowel movements, nor was the administration of butylscopolamine, dicyclomine, glucagon or similar drugs carried out. We have carefully reviewed each case to avoid significant image misalignments. But in the future, image registration may be needed to improve the accuracy of quantitative analysis.
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Nevertheless, our study focuses on the specific relationship between pre-CRT MR imaging values and pathological response using both volume-averaged and voxelized analysis. Through a systematic analysis of multi-parametric MR imaging features, we are able to build models with improved predictive value over conventional imaging metrics. This is encouraging, suggesting the wealth of imaging radiomics should be further explored to help tailoring the treatment into the era of personalized medicine. Combined 365 quantitative imaging features may lead to better prognostic value of allowing earlier treatment alternation and more accurate non-invasive surveillance.
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